P-glycoprotein inhibitors improve effective dose and time of pregabalin to inhibit intermittent cold stress-induced central pain
Pregabalin (PGB) is a valuable therapeutic drug against chronic pain. Here we attempted to perform the combinatorial drug therapy with P-glycoprotein (P-gp) inhibitors to lower therapeutic dosage of PGB in the intermittent cold stress-induced fibromyalgia-like pain model. Single intracerebroventricu...
Main Authors: | Takehiro Mukae, Wakako Fujita, Hiroshi Ueda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861316000037 |
Similar Items
-
Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia
by: Bhusal S, et al.
Published: (2016-02-01) -
A comparison of the effectiveness of amitriptilin and pregabalin treatment in fibromyalgia patients
by: Günseli Acet, et al.
Published: (2017-08-01) -
Improvement in pain severity category in clinical trials of pregabalin
by: Parsons B, et al.
Published: (2016-10-01) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
by: Paolo Marchettini, et al.
Published: (2005-05-01) -
Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
by: Serpell M, et al.
Published: (2017-07-01)